Imaging the inflammatory phenotype in migraine
- PMID: 35650524
- PMCID: PMC9158262
- DOI: 10.1186/s10194-022-01430-y
Imaging the inflammatory phenotype in migraine
Abstract
Several preclinical and clinical lines of evidence suggest a role of neuroinflammation in migraine. Neuroimaging offers the possibility to investigate and localize neuroinflammation in vivo in patients with migraine, and to characterize specific inflammatory constituents, such as vascular permeability, and macrophage or microglia activity. Despite all imaging data accumulated on neuroinflammation across the past three decades, an overview of the imaging evidence of neuroinflammation in migraine is still missing.We conducted a systematic review in the Pubmed and Embase databases to evaluate existing imaging data on inflammation in migraine, and to identify gaps in the literature. We included 20 studies investigating migraine without aura (N = 4), migraine with aura (N = 8), both migraine with and without aura (N = 3), or hemiplegic migraine (N = 5).In migraine without aura, macrophage activation was not evident. In migraine with aura, imaging evidence suggested microglial and parameningeal inflammatory activity. Increased vascular permeability was mostly found in hemiplegic migraine, and was atypical in migraine with and without aura. Based on the weight of existing and emerging data, we show that most studies have concentrated on demonstrating increased vascular permeability as a marker of neuroinflammation, with tools that may not have been optimal. In the future, novel, more sensitive techniques, as well as imaging tracers delineating specific inflammatory pathways may further bridge the gap between preclinical and clinical findings.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interest.
Figures
Similar articles
-
Interventions for interpersonal communication about end of life care between health practitioners and affected people.Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2. Cochrane Database Syst Rev. 2022. PMID: 35802350 Free PMC article.
-
Botulinum toxins for the prevention of migraine in adults.Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD011616. doi: 10.1002/14651858.CD011616.pub2. Cochrane Database Syst Rev. 2018. PMID: 29939406 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Measures implemented in the school setting to contain the COVID-19 pandemic.Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 May 2;5:CD015029. doi: 10.1002/14651858.CD015029.pub2. PMID: 35037252 Free PMC article. Updated.
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
Cited by
-
Oxidative Stress and Migraine.Mol Neurobiol. 2024 Oct;61(10):8344-8360. doi: 10.1007/s12035-024-04114-7. Epub 2024 Mar 18. Mol Neurobiol. 2024. PMID: 38499906 Review.
-
Unraveling the interplay of neuroinflammatory signaling between parenchymal and meningeal cells in migraine headache.J Headache Pain. 2024 Jul 31;25(1):124. doi: 10.1186/s10194-024-01827-x. J Headache Pain. 2024. PMID: 39080518 Free PMC article. Review.
-
[Multiple comorbidities with migraine-Is there a common cause?].Schmerz. 2025 Aug 28. doi: 10.1007/s00482-025-00901-w. Online ahead of print. Schmerz. 2025. PMID: 40877489 Review. German.
-
The CLDN5 gene at the blood-brain barrier in health and disease.Fluids Barriers CNS. 2023 Mar 28;20(1):22. doi: 10.1186/s12987-023-00424-5. Fluids Barriers CNS. 2023. PMID: 36978081 Free PMC article. Review.
-
Primary headache disorders: From pathophysiology to neurostimulation therapies.Heliyon. 2023 Mar 23;9(4):e14786. doi: 10.1016/j.heliyon.2023.e14786. eCollection 2023 Apr. Heliyon. 2023. PMID: 37077680 Free PMC article. Review.
References
-
- IHS The International Classification of Headache Disorders, 3rd edition (beta version), Headache Classification Committee of the International Headache Society. Cephalalgia. 2018;38:629–808. - PubMed
-
- Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 1993;43:S16–S20. - PubMed
-
- Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8:136–142. - PubMed
-
- Magni G, Boccazzi M, Bodini A, et al. Basal astrocyte and microglia activation in the central nervous system of Familial Hemiplegic Migraine Type I mice. Cephalalgia. 2019;39:1809. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous